Overdose-Prevention Grant Heralded On Grand
Roughly $10 million in federal aid will flow to the New Haven area over the next five years to help municipal health departments take a regional approach in combating the opioid epidemic. YSPH Professor Robert Heimer is helping to lead the effort.Source: New Haven Independent
Marijuana and Nicotine Vaping Prevention Videogame Coming to Three CT Middle Schools
A top public health concern among today’s adolescents is the widespread use of nicotine and marijuana vaping devices. Now, two researchers at Yale School of Medicine, Kimberly Hieftje, PhD, and Deepa Camenga, MD, MHS, are teaming up with the Connecticut Department of Public Health (DPH) to bring a classroom-based virtual reality (VR) nicotine and marijuana vaping prevention videogame to students in three Connecticut middle schools.
YSPH alumna Margaret Mayer embraces challenge of grant management at the National Cancer Institute
This Alumni Spotlight focuses on Margaret Mayer, PhD ’19 (Chronic Disease Epidemiology), MPH ’16 (Chronic Disease Epidemiology), the program director in the Tobacco Cancer Research Branch at the National Cancer Institute.
NIDA Invests Nearly $7M to Address the Opioid Crisis Among Women Who Experience Intimate Partner Violence
The National Institutes of Health and National Institute on Drug Abuse has awarded nearly $7 million to MPIs Tami Sullivan, PhD (Psychiatry and Public Health); E. Jennifer Edelman, MD, MHS (Internal Medicine and Public Health); and Dawn Johnson, PhD (University of Akron Department of Psychology) to study medication for opioid use disorder treatment retention among women who experience intimate partner violence.
FDA Makes a Move to Ban Menthol and Flavored Cigarettes
Public health experts have long urged the government to take action against menthol-flavored cigarettes, and the Food and Drug Administration is finally stepping up. “Eliminating menthol in cigarettes would reduce youth from starting to smoke and similarly, eliminating all flavors in e-cigarettes would drastically reduce youths from starting to use tobacco products,” says YSPH's Jody Sindelar.Source: The Messenger
Tobacco purchases rise following restrictions on e-cigarette sales
The immense popularity of electronic cigarettes, or e-cigarettes, among young people has led many policymakers to restrict the sale of flavored varieties. But rather than nudging people away from “vapes,” as these e-cigarettes are called, such measures could backfire by driving users to instead buy conventional cigarettes, according to researchers at the Yale School of Public Health.
Chemical additives replace menthol in new ‘non-menthol’ cigarettes
Some “non-menthol” cigarettes that are being marketed as a “fresh” alternative in states where traditional menthol cigarettes are banned use synthetic chemicals to mimic menthol’s distinct cooling sensations, researchers at Yale and Duke University have found.
Addiction Medicine Fellowship Training at Yale Expands To Advanced Practice Providers
Yale School of Medicine established an addiction medicine fellowship program for advanced practice providers, including physician assistants and advanced practice registered nurses as part of the Substance Use Skills Training to Advance INtegrated care project.
UK Proposes Smoking Ban — Could the US Be Next?
Children who turn 14 years old this year will never be able to legally buy a cigarette under a new proposal by U.K. Prime Minister Rishi Sunak. YSPH Professor Jody Sindelar says the policy might not be productive or strong enough for the U.S.Source: The Messenger
Legal cocaine is coming, this Canadian startup predicts
The Safe Supply Streaming Co., a startup listed on the Canadian Securities Exchange, is betting on a third wave of policy changes around hard drugs. YSPH Professor Jason Hockenberry is concerned legalization would worsen existing problems with addiction.Source: Financial Post
Xylazine presents new challenges for emergency treatment of overdose
Protocols for first responders and harm reduction workers should be reviewed and updated to account for the increased presence of the animal tranquilizer xylazine in the illicit street drug supply, according to a new study led by researchers at the Yale School of Public Health.
Opara receives $3.5 million grant to curb urban drug use, involve youth in research
Yale School of Public Health Associate Professor Ijeoma Opara has received the NIDA (National Institute on Drug Abuse) Racial Equity Visionary Award. The award is a NIDA DP1 grant for $3.5 million over five years that will allow her to work within predominantly urban neighborhoods to curb substance use among racial/ethnic minorities.
Highlighting Gender-based Differences in Alcohol-associated Hepatitis
During her Yale School of Medicine fellowships in gastroenterology and transplant hepatology, Anahita Rabiee, MD, MHS, instructor of medicine (digestive diseases), saw a lot of men and women admitted with alcohol-associated hepatitis—the most severe form of alcohol-related liver disease—at Yale New Haven Hospital. At the time, she couldn’t help noticing that women with this condition tended to have worse outcomes than men.
Teens with addiction are often left to detox without medication
Teens who land in emergency rooms with an opioid overdose generally receive naloxone to reverse the effects of dangerous drugs in their system and are sent home with a list of places they can go for follow-up care. But too often, those teens never seek additional help. They are left to suffer through the agony of withdrawal with no medications to ease their cravings. As a result, many, seeking relief, go back to opioids, often with tragic consequences.Source: CNN Health
Ukrainian Refugees Face High Barriers to Opioid Use Disorder Treatment, Yale Study Finds
Many Ukrainian refugees fleeing the war have encountered obstacles when seeking therapies for opioid use disorder in European Union countries, a new Yale-led study finds. The study examines the barriers to opioid agonist therapies (OAT) and providers’ responses to increased demand in OAT enrollment.
The Importance of Considering Sex and Gender in Tobacco Regulation
In a recent JAMA Viewpoint, three Yale Psychiatry faculty members showcase why a greater focus on sex and gender differences in FDA regulatory action on tobacco is essential to public health. They highlight specific tobacco regulations under consideration by FDA and offer approaches as to how the impact of sex and gender can be integrated into regulatory actions.